Medical device maker Hanger to be taken private in USD 1.25 billion deal

Published On 2022-07-24 07:00 GMT   |   Update On 2022-07-24 07:01 GMT
Advertisement

New Delhi: Medical devices maker Hanger Inc said on Thursday it has agreed to be taken private by healthcare investment firm Patient Square Capital in a deal worth about $1.25 billion, sending its shares up more than 20%.

Under the terms of the agreement, which has been unanimously approved by Hanger's Board of Directors, the prosthetic care provider's stockholders will receive $18.75 per share in cash, representing a 27% premium to stock's closing price on Thursday.

Advertisement

Hanger shares moved up 23.5% to $18.22 post the bell, following news of the take-private deal.

The healthcare sector has outperformed in recent recessionary periods, making them an attractive target for investors looking for assets that can weather a potential downturn, as recession worries grow amid aggressive monetary policy tightening from the Federal Reserve. 

Hanger, headquartered in Austin, Texas, provides products and services that assist in enhancing or restoring the physical capabilities of patients with disabilities or injuries.

The transaction is expected to close in the fourth quarter of 2022 and Vinit Asar, the current Chief Executive Officer of Hanger, will continue to lead the company

Read also: Govt unveils 3 schemes for MSMEs in pharma sector



Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News